Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry
Burcu F. Darst, Jiayi Shen, Ravi K. Madduri, Alexis A. Rodriguez, Yukai Xiao, Xin Sheng, Edward J. Saunders, Tokhir Dadaev, Mark N. Brook, Thomas J. Hoffmann, Kenneth Muir, Peggy Wan, Loic Le Marchand, Lynne Wilkens, Ying Wang, Johanna Schleutker, Robert J. MacInnis, Cezary Cybulski, David E. Neal, Børge G. Nordestgaard, Sune F. Nielsen, Jyotsna Batra, Judith A. Clements, Australian Prostate Cancer BioResource, Henrik Grönberg, Nora Pashayan, Ruth C. Travis, Jong Y. Park, Demetrius Albanes, Stephanie Weinstein, Lorelei A. Mucci, David J. Hunter, Kathryn L. Penney, Catherine M. Tangen, Robert J. Hamilton, Marie-Élise Parent, Janet L. Stanford, Stella Koutros, Alicja Wolk, Karina D. Sørensen, William J. Blot, Edward D. Yeboah, James E. Mensah, Yong-Jie Lu, Daniel J. Schaid, Stephen N. Thibodeau, Catharine M. West, Christiane Maier, Adam S. Kibel, Géraldine Cancel-Tassin, Florence Menegaux, Esther M. John, Eli Marie Grindedal, Kay-Tee Khaw, Sue A. Ingles, Ana Vega, Barry S. Rosenstein, Manuel R. Teixeira, NC-LA PCaP Investigators, Manolis Kogevinas, Lisa Cannon-Albright, Chad Huff, Luc Multigner, Radka Kaneva, Robin J. Leach, Hermann Brenner, Ann W. Hsing, Rick A. Kittles, Adam B. Murphy, Christopher J. Logothetis, Susan L. Neuhausen, William B. Isaacs, Barbara Nemesure, Anselm J. Hennis, John Carpten, Hardev Pandha, Kim De Ruyck, Jianfeng Xu, Azad Razack, Soo-Hwang Teo, Canary PASS Investigators, Lisa F. Newcomb, Jay H. Fowke, Christine Neslund-Dudas, Benjamin A. Rybicki, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Jose Esteban Castelao, Paul A. Townsend, Dana C. Crawford, Gyorgy Petrovics, Graham Casey, Monique J. Roobol, Jennifer F. Hu, Sonja I. Berndt, Stephen K. Van Den Eeden, Douglas F. Easton, Stephen J. Chanock, Michael B. Cook, Fredrik Wiklund, John S. Witte, Rosalind A. Eeles, Zsofia Kote-Jarai, Stephen Watya, John M. Gaziano, Amy C. Justice, David V. Conti, Christopher A. Haiman
doi: https://doi.org/10.1101/2023.05.12.23289860
Burcu F. Darst
1Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
2Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
Jiayi Shen
1Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Ravi K. Madduri
3Argonne National Laboratory, Lemont, IL, USA
Alexis A. Rodriguez
3Argonne National Laboratory, Lemont, IL, USA
Yukai Xiao
3Argonne National Laboratory, Lemont, IL, USA
Xin Sheng
1Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Edward J. Saunders
4The Institute of Cancer Research, London, UK
Tokhir Dadaev
4The Institute of Cancer Research, London, UK
Mark N. Brook
4The Institute of Cancer Research, London, UK
Thomas J. Hoffmann
5Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
Kenneth Muir
6Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Peggy Wan
1Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Loic Le Marchand
7Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
Lynne Wilkens
7Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
Ying Wang
8Department of Population Science, American Cancer Society, Atlanta, GA, USA
Johanna Schleutker
9Institute of Biomedicine, University of Turku, Finland
Robert J. MacInnis
10Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia
11Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia
Cezary Cybulski
12International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
David E. Neal
13Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK
14University of Cambridge, Department of Oncology, Addenbrooke’s Hospital, Cambridge, UK
15Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge UK
Børge G. Nordestgaard
16Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
17Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Copenhagen, Denmark
Sune F. Nielsen
16Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
17Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Copenhagen, Denmark
Jyotsna Batra
18Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia
19Translational Research Institute, Brisbane, Queensland, Australia
Judith A. Clements
18Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia
19Translational Research Institute, Brisbane, Queensland, Australia
19Translational Research Institute, Brisbane, Queensland, Australia
20Australian Prostate Cancer Research Centre-Qld, Queensland University of Technology, Brisbane; Prostate Cancer Research Program, Monash University, Melbourne; Dame Roma Mitchell Cancer Centre, University of Adelaide, Adelaide; Chris O’Brien Lifehouse and The Kinghorn Cancer Centre, Sydney, Australia
Henrik Grönberg
21Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
Nora Pashayan
22University College London, Department of Applied Health Research, London,UK
23Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK
Ruth C. Travis
24Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
Jong Y. Park
25Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA
Demetrius Albanes
26Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Stephanie Weinstein
26Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Lorelei A. Mucci
27Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA
David J. Hunter
28Nuffield Department of Population Health, University of Oxford, Oxford, UK
Kathryn L. Penney
29Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, USA
Catherine M. Tangen
30SWOG Statistical Center, Fred Hutchinson Cancer Center, Seattle, WA, USA
Robert J. Hamilton
31Dept. of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Canada
32Dept. of Surgery (Urology), University of Toronto, Canada
Marie-Élise Parent
33Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique, Laval, QC, Canada
34Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal, QC, Canada
Janet L. Stanford
2Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
35Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA
Stella Koutros
26Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Alicja Wolk
36Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
37Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Karina D. Sørensen
38Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark
39Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark
William J. Blot
40Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
41International Epidemiology Institute, Rockville, MD, USA
Edward D. Yeboah
42University of Ghana Medical School, Accra, Ghana
43Korle Bu Teaching Hospital, Accra, Ghana
James E. Mensah
42University of Ghana Medical School, Accra, Ghana
43Korle Bu Teaching Hospital, Accra, Ghana
Yong-Jie Lu
44Centre for Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK
Daniel J. Schaid
45Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA
Stephen N. Thibodeau
46Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Catharine M. West
47Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester, UK
Christiane Maier
48Humangenetik Tuebingen, Tuebingen, Germany
Adam S. Kibel
49Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA
Géraldine Cancel-Tassin
50CeRePP, Tenon Hospital, Paris, France
51Sorbonne Universite, GRC 5 Predictive Onco-urology, Tenon Hospital, Paris, France
Florence Menegaux
52“Exposome and Heredity”, CESP (UMR 1018), Faculté de Médecine, Université Paris-Saclay, Inserm, Gustave Roussy, Villejuif, France
Esther M. John
53Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA
54Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA
55Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA
Eli Marie Grindedal
56Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
Kay-Tee Khaw
57Clinical Gerontology Unit, University of Cambridge, Cambridge, UK
Sue A. Ingles
58Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Ana Vega
59Fundación Pública Galega Medicina Xenómica, Santiago De Compostela, Spain
60Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain
61Centro de Investigación en Red de Enfermedades Raras (CIBERER), Spain
Barry S. Rosenstein
62Department of Radiation Oncology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
63Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Manuel R. Teixeira
64Department of Genetics, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal
65Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
66Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
67Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
68Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA
Manolis Kogevinas
69ISGlobal, Barcelona, Spain
70IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
71Universitat Pompeu Fabra (UPF), Barcelona, Spain
72CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
Lisa Cannon-Albright
73Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA
74George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, USA
Chad Huff
75Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Luc Multigner
76Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), Rennes, France
Radka Kaneva
77Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria
Robin J. Leach
78Department of Urology, Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio Texas, USA
Hermann Brenner
79Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
80German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
81Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
Ann W. Hsing
82Department of Medicine and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA
Rick A. Kittles
83Division of Health Equities, Department of Population Sciences, City of Hope, Duarte, CA, USA
Adam B. Murphy
84Department of Urology, Northwestern University, Chicago, IL, USA
Christopher J. Logothetis
85The University of Texas M. D. Anderson Cancer Center, Department of Genitourinary Medical Oncology, Houston, TX, USA
Susan L. Neuhausen
86Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA
William B. Isaacs
87James Buchanan Brady Urological Institute, Johns Hopkins Hospital and Medical Institution, Baltimore, MD, USA
Barbara Nemesure
88Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA
Anselm J. Hennis
88Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA
89Chronic Disease Research Centre and Faculty of Medical Sciences, University of the West Indies, Bridgetown, Barbados
John Carpten
90Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Hardev Pandha
91Faculty of Health and Medical Sciences, The University of Surrey, Guildford, Surrey, UK
Kim De Ruyck
92Ghent University, Faculty of Medicine and Health Sciences, Basic Medical Sciences, Gent, Belgium
Jianfeng Xu
93Program for Personalized Cancer Care and Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA
Azad Razack
94Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
Soo-Hwang Teo
95Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia
2Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
96Department of Urology, University of Washington, Seattle, WA, USA
Lisa F. Newcomb
2Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
96Department of Urology, University of Washington, Seattle, WA, USA
Jay H. Fowke
97Division of Epidemiology, Department of Preventive Medicine, The University of Tennessee Health Science Center, TN, USA
Christine Neslund-Dudas
98Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA
Benjamin A. Rybicki
98Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA
Marija Gamulin
99Department of Oncology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia
Nawaid Usmani
100Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
101Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada
Frank Claessens
102Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, Leuven, Belgium
Manuela Gago-Dominguez
103Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain
104University of California San Diego, Moores Cancer Center, La Jolla, CA, USA
Jose Esteban Castelao
105Genetic Oncology Unit, CHUVI Hospital, Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Biomédica Galicia Sur (IISGS), Vigo (Pontevedra), Spain
Paul A. Townsend
106Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, UK
107The University of Surrey, Guildford, Surrey, UK
Dana C. Crawford
108Case Western Reserve University, Department of Population and Quantitative Health Sciences, Cleveland Institute for Computational Biology, Cleveland, OH, USA
Gyorgy Petrovics
109Center for Prostate Disease Research, Uniformed Services University, Bethesda, MD, USA
Graham Casey
110Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA
Monique J. Roobol
111109 Department of Urology, Erasmus University Medical Center, Cancer Institute, Rotterdam, The Netherlands
Jennifer F. Hu
112The University of Miami School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA
Sonja I. Berndt
26Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Stephen K. Van Den Eeden
113Division of Research, Kaiser Permanente, Northern California, Oakland, CA, USA
114Department of Urology, University of California San Francisco, San Francisco, CA, USA
Douglas F. Easton
23Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK
Stephen J. Chanock
26Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Michael B. Cook
26Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Fredrik Wiklund
21Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
John S. Witte
115Department of Epidemiology and Population Health, Department of Biomedical Data Science, Stanford Cancer Institute, Stanford, CA, USA
Rosalind A. Eeles
116The Institute of Cancer Research, Sutton, London, UK
117Royal Marsden NHS Foundation Trust, London, UK
Zsofia Kote-Jarai
116The Institute of Cancer Research, Sutton, London, UK
Stephen Watya
118School of Public Health, Makerere University College of Health Sciences, Kampala Uganda
John M. Gaziano
119VA Boston Healthcare System, Boston, MA, USA
120Department of Medicine, Harvard Medical School, Boston, MA, USA
121Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
Amy C. Justice
122VA Connecticut Healthcare System, West Haven, CT, USA
123Yale School of Medicine, New Haven, CT, USA
David V. Conti
1Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Christopher A. Haiman
1Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Posted May 15, 2023.
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry
Burcu F. Darst, Jiayi Shen, Ravi K. Madduri, Alexis A. Rodriguez, Yukai Xiao, Xin Sheng, Edward J. Saunders, Tokhir Dadaev, Mark N. Brook, Thomas J. Hoffmann, Kenneth Muir, Peggy Wan, Loic Le Marchand, Lynne Wilkens, Ying Wang, Johanna Schleutker, Robert J. MacInnis, Cezary Cybulski, David E. Neal, Børge G. Nordestgaard, Sune F. Nielsen, Jyotsna Batra, Judith A. Clements, Australian Prostate Cancer BioResource, Henrik Grönberg, Nora Pashayan, Ruth C. Travis, Jong Y. Park, Demetrius Albanes, Stephanie Weinstein, Lorelei A. Mucci, David J. Hunter, Kathryn L. Penney, Catherine M. Tangen, Robert J. Hamilton, Marie-Élise Parent, Janet L. Stanford, Stella Koutros, Alicja Wolk, Karina D. Sørensen, William J. Blot, Edward D. Yeboah, James E. Mensah, Yong-Jie Lu, Daniel J. Schaid, Stephen N. Thibodeau, Catharine M. West, Christiane Maier, Adam S. Kibel, Géraldine Cancel-Tassin, Florence Menegaux, Esther M. John, Eli Marie Grindedal, Kay-Tee Khaw, Sue A. Ingles, Ana Vega, Barry S. Rosenstein, Manuel R. Teixeira, NC-LA PCaP Investigators, Manolis Kogevinas, Lisa Cannon-Albright, Chad Huff, Luc Multigner, Radka Kaneva, Robin J. Leach, Hermann Brenner, Ann W. Hsing, Rick A. Kittles, Adam B. Murphy, Christopher J. Logothetis, Susan L. Neuhausen, William B. Isaacs, Barbara Nemesure, Anselm J. Hennis, John Carpten, Hardev Pandha, Kim De Ruyck, Jianfeng Xu, Azad Razack, Soo-Hwang Teo, Canary PASS Investigators, Lisa F. Newcomb, Jay H. Fowke, Christine Neslund-Dudas, Benjamin A. Rybicki, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Jose Esteban Castelao, Paul A. Townsend, Dana C. Crawford, Gyorgy Petrovics, Graham Casey, Monique J. Roobol, Jennifer F. Hu, Sonja I. Berndt, Stephen K. Van Den Eeden, Douglas F. Easton, Stephen J. Chanock, Michael B. Cook, Fredrik Wiklund, John S. Witte, Rosalind A. Eeles, Zsofia Kote-Jarai, Stephen Watya, John M. Gaziano, Amy C. Justice, David V. Conti, Christopher A. Haiman
medRxiv 2023.05.12.23289860; doi: https://doi.org/10.1101/2023.05.12.23289860
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry
Burcu F. Darst, Jiayi Shen, Ravi K. Madduri, Alexis A. Rodriguez, Yukai Xiao, Xin Sheng, Edward J. Saunders, Tokhir Dadaev, Mark N. Brook, Thomas J. Hoffmann, Kenneth Muir, Peggy Wan, Loic Le Marchand, Lynne Wilkens, Ying Wang, Johanna Schleutker, Robert J. MacInnis, Cezary Cybulski, David E. Neal, Børge G. Nordestgaard, Sune F. Nielsen, Jyotsna Batra, Judith A. Clements, Australian Prostate Cancer BioResource, Henrik Grönberg, Nora Pashayan, Ruth C. Travis, Jong Y. Park, Demetrius Albanes, Stephanie Weinstein, Lorelei A. Mucci, David J. Hunter, Kathryn L. Penney, Catherine M. Tangen, Robert J. Hamilton, Marie-Élise Parent, Janet L. Stanford, Stella Koutros, Alicja Wolk, Karina D. Sørensen, William J. Blot, Edward D. Yeboah, James E. Mensah, Yong-Jie Lu, Daniel J. Schaid, Stephen N. Thibodeau, Catharine M. West, Christiane Maier, Adam S. Kibel, Géraldine Cancel-Tassin, Florence Menegaux, Esther M. John, Eli Marie Grindedal, Kay-Tee Khaw, Sue A. Ingles, Ana Vega, Barry S. Rosenstein, Manuel R. Teixeira, NC-LA PCaP Investigators, Manolis Kogevinas, Lisa Cannon-Albright, Chad Huff, Luc Multigner, Radka Kaneva, Robin J. Leach, Hermann Brenner, Ann W. Hsing, Rick A. Kittles, Adam B. Murphy, Christopher J. Logothetis, Susan L. Neuhausen, William B. Isaacs, Barbara Nemesure, Anselm J. Hennis, John Carpten, Hardev Pandha, Kim De Ruyck, Jianfeng Xu, Azad Razack, Soo-Hwang Teo, Canary PASS Investigators, Lisa F. Newcomb, Jay H. Fowke, Christine Neslund-Dudas, Benjamin A. Rybicki, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Jose Esteban Castelao, Paul A. Townsend, Dana C. Crawford, Gyorgy Petrovics, Graham Casey, Monique J. Roobol, Jennifer F. Hu, Sonja I. Berndt, Stephen K. Van Den Eeden, Douglas F. Easton, Stephen J. Chanock, Michael B. Cook, Fredrik Wiklund, John S. Witte, Rosalind A. Eeles, Zsofia Kote-Jarai, Stephen Watya, John M. Gaziano, Amy C. Justice, David V. Conti, Christopher A. Haiman
medRxiv 2023.05.12.23289860; doi: https://doi.org/10.1101/2023.05.12.23289860
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12634)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4496)
- Geriatric Medicine (411)
- Health Economics (718)
- Health Informatics (2877)
- Health Policy (1060)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4264)
- Nursing (228)
- Nutrition (626)
- Oncology (2233)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6845)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)